Propanc Biopharma, Inc. Common Stock (PPCB) — Net Asset Quality Index
Propanc Biopharma, Inc. Common Stock (PPCB) has a Net Asset Quality Index of 69.2% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $15.11 Million minus total liabilities of $4.66 Million yields net assets of $10.45 Million. A higher index indicates a stronger, lower-leverage balance sheet. Also explore Propanc Biopharma, Inc. Common Stock assets under control for the complete picture of this company's asset base.
Quality Index
Net Assets
Total Assets
Total Liabilities
Propanc Biopharma, Inc. Common Stock Net Asset Quality Index Over Time (2010–2025)
This chart shows how Propanc Biopharma, Inc. Common Stock's Net Asset Quality Index has evolved across 16 annual periods from 2010 to 2025. As of December 2025, the index stands at 69.2%, representing net assets of $10.45 Million against total assets of $15.11 Million USD. See Propanc Biopharma, Inc. Common Stock working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Propanc Biopharma, Inc. Common Stock (2010–2025)
The table below presents the year-by-year Net Asset Quality Index for Propanc Biopharma, Inc. Common Stock from 2010 to 2025, covering 16 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Propanc Biopharma, Inc. Common Stock market cap and net worth.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 70.8% | $13.91 Million | $19.63 Million | $5.73 Million | ▲ +5293.1 pp |
| 2024 | -5222.2% | $-3.78 Million | $72.36K | $3.85 Million | ▼ -55.2 pp |
| 2023 | -5167.1% | $-3.12 Million | $60.33K | $3.18 Million | ▼ -1463.9 pp |
| 2022 | -3703.1% | $-3.02 Million | $81.65K | $3.11 Million | ▲ +19711.7 pp |
| 2021 | -23414.8% | $-3.07 Million | $13.10K | $3.08 Million | ▼ -19718.6 pp |
| 2020 | -3696.2% | $-3.64 Million | $98.52K | $3.74 Million | ▲ +535.1 pp |
| 2019 | -4231.3% | $-4.30 Million | $101.65K | $4.40 Million | ▲ +5226.9 pp |
| 2018 | -9458.2% | $-6.75 Million | $71.39K | $6.82 Million | ▼ -3734.2 pp |
| 2017 | -5724.0% | $-5.44 Million | $95.07K | $5.54 Million | ▼ -5047.4 pp |
| 2016 | -676.6% | $-2.57 Million | $379.14K | $2.94 Million | ▼ -189.7 pp |
| 2015 | -487.0% | $-3.05 Million | $627.07K | $3.68 Million | ▲ +751.2 pp |
| 2014 | -1238.1% | $-1.41 Million | $113.75K | $1.52 Million | ▲ +44124.0 pp |
| 2013 | -45362.1% | $-792.48K | $1.75K | $794.22K | ▼ -44199.5 pp |
| 2012 | -1162.6% | $-537.92K | $46.27K | $584.19K | ▼ -1259.8 pp |
| 2011 | 97.2% | $10.51 Million | $10.81 Million | $306.85K | ▲ +523.3 pp |
| 2010 | -426.1% | $-186.90K | $43.86K | $230.76K | — |